Bone mineral density and disorders of mineral metabolism in chronic liver disease. 2009

Joe George, and Hosahithlu K Ganesh, and Shrikrishna Acharya, and Tushar R Bandgar, and Vyankatesh Shivane, and Anjana Karvat, and Shobna J Bhatia, and Samir Shah, and Padmavathy S Menon, and Nalini Shah
Department of Endocrinology, KEM Hospital, Parel, Mumbai 400012, India.

OBJECTIVE To estimate the prevalence and identify the risk factors for metabolic bone disease in patients with cirrhosis. METHODS The study was performed on 72 Indian patients with cirrhosis (63 male, nine female; aged < 50 years). Etiology of cirrhosis was alcoholism (n = 37), hepatitis B (n = 25) and hepatitis C (n = 10). Twenty-three patients belonged to Child class A, while 39 were in class B and 10 in class C. Secondary causes for metabolic bone disease and osteoporosis were ruled out. Sunlight exposure, physical activity and dietary constituents were calculated. Complete metabolic profiles were derived, and bone mineral density (BMD) was measured using dual energy X ray absorptiometry. Low BMD was defined as a Z score below -2. RESULTS Low BMD was found in 68% of patients. Lumbar spine was the most frequently and severely affected site. Risk factors for low BMD included low physical activity, decreased sunlight exposure, and low lean body mass. Calcium intake was adequate, with unfavorable calcium: protein ratio and calcium: phosphorus ratio. Vitamin D deficiency was highly prevalent (92%). There was a high incidence of hypogonadism (41%). Serum estradiol level was elevated significantly in patients with normal BMD. Insulin-like growth factor (IGF) 1 and IGF binding protein 3 levels were below the age-related normal range in both groups. IGF-1 was significantly lower in patients with low BMD. Serum osteocalcin level was low (68%) and urinary deoxypyridinoline to creatinine ratio was high (79%), which demonstrated low bone formation with high resorption. CONCLUSIONS Patients with cirrhosis have low BMD. Contributory factors are reduced physical activity, low lean body mass, vitamin D deficiency and hypogonadism and low IGF-1 level.

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D001851 Bone Diseases, Metabolic Diseases that affect the METABOLIC PROCESSES of BONE TISSUE. Low Bone Density,Low Bone Mineral Density,Osteopenia,Metabolic Bone Diseases,Bone Density, Low,Bone Disease, Metabolic,Low Bone Densities,Metabolic Bone Disease,Osteopenias
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females

Related Publications

Joe George, and Hosahithlu K Ganesh, and Shrikrishna Acharya, and Tushar R Bandgar, and Vyankatesh Shivane, and Anjana Karvat, and Shobna J Bhatia, and Samir Shah, and Padmavathy S Menon, and Nalini Shah
November 2005, European journal of obstetrics, gynecology, and reproductive biology,
Joe George, and Hosahithlu K Ganesh, and Shrikrishna Acharya, and Tushar R Bandgar, and Vyankatesh Shivane, and Anjana Karvat, and Shobna J Bhatia, and Samir Shah, and Padmavathy S Menon, and Nalini Shah
May 2013, The Journal of clinical endocrinology and metabolism,
Joe George, and Hosahithlu K Ganesh, and Shrikrishna Acharya, and Tushar R Bandgar, and Vyankatesh Shivane, and Anjana Karvat, and Shobna J Bhatia, and Samir Shah, and Padmavathy S Menon, and Nalini Shah
July 2016, Kardiologiia,
Joe George, and Hosahithlu K Ganesh, and Shrikrishna Acharya, and Tushar R Bandgar, and Vyankatesh Shivane, and Anjana Karvat, and Shobna J Bhatia, and Samir Shah, and Padmavathy S Menon, and Nalini Shah
January 2014, Tropical gastroenterology : official journal of the Digestive Diseases Foundation,
Joe George, and Hosahithlu K Ganesh, and Shrikrishna Acharya, and Tushar R Bandgar, and Vyankatesh Shivane, and Anjana Karvat, and Shobna J Bhatia, and Samir Shah, and Padmavathy S Menon, and Nalini Shah
June 2017, Minerva endocrinologica,
Joe George, and Hosahithlu K Ganesh, and Shrikrishna Acharya, and Tushar R Bandgar, and Vyankatesh Shivane, and Anjana Karvat, and Shobna J Bhatia, and Samir Shah, and Padmavathy S Menon, and Nalini Shah
March 2011, JAMA,
Joe George, and Hosahithlu K Ganesh, and Shrikrishna Acharya, and Tushar R Bandgar, and Vyankatesh Shivane, and Anjana Karvat, and Shobna J Bhatia, and Samir Shah, and Padmavathy S Menon, and Nalini Shah
April 2016, Journal of investigative medicine : the official publication of the American Federation for Clinical Research,
Joe George, and Hosahithlu K Ganesh, and Shrikrishna Acharya, and Tushar R Bandgar, and Vyankatesh Shivane, and Anjana Karvat, and Shobna J Bhatia, and Samir Shah, and Padmavathy S Menon, and Nalini Shah
October 2018, Nephrology (Carlton, Vic.),
Joe George, and Hosahithlu K Ganesh, and Shrikrishna Acharya, and Tushar R Bandgar, and Vyankatesh Shivane, and Anjana Karvat, and Shobna J Bhatia, and Samir Shah, and Padmavathy S Menon, and Nalini Shah
January 2013, Revista espanola de enfermedades digestivas,
Joe George, and Hosahithlu K Ganesh, and Shrikrishna Acharya, and Tushar R Bandgar, and Vyankatesh Shivane, and Anjana Karvat, and Shobna J Bhatia, and Samir Shah, and Padmavathy S Menon, and Nalini Shah
December 2006, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology,
Copied contents to your clipboard!